Clive A. Meanwell's most recent trade in Metsera Inc. was a trade of 12,767,462 Common Stock done . Disclosure was reported to the exchange on Nov. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Metsera Inc | Clive A. Meanwell | Director, EXECUTIVE CHAIRMAN | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Nov 2025 | 12,767,462 | 0 | - | - | Common Stock | |
| Metsera Inc | Clive A. Meanwell | Director, EXECUTIVE CHAIRMAN | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Nov 2025 | 297,907 | 0 | - | - | Stock Option (right to buy) | |
| Metsera Inc | Clive A. Meanwell | Director, EXECUTIVE CHAIRMAN | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Nov 2025 | 32,250 | 0 | - | - | Stock Option (right to buy) | |
| Metsera Inc | Clive A. Meanwell | Director, EXECUTIVE CHAIRMAN | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Nov 2025 | 5,375 | 0 | - | - | Common Stock | |
| Metsera Inc | Clive A. Meanwell | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2025 | 5,375 | 5,375 | - | - | Restricted Stock Unit | |
| Fractyl Health Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option | |
| Metsera Inc | Clive A. Meanwell | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 32,250 | 32,250 | - | - | Stock Option (Right to Buy) | |
| Fractyl Health Inc | Clive A. Meanwell | Director | 06 Feb 2024 | 596,352 | 0 | - | - | Series F Preferred Stock | ||
| Fractyl Health Inc | Clive A. Meanwell | Director | 06 Feb 2024 | 277,890 | 277,890 | - | - | Common Stock | ||
| Fractyl Health Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 45,000 | 45,000 | - | - | Stock Option | |
| Invivyd Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| EQRx Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 226 | 43,172 | - | - | Earn-out Shares | |
| EQRx Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 101,010 | 101,010 | - | - | Stock Option (Right to Buy) | |
| Invivyd Inc | Clive A. Meanwell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| EQRx Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 313,500 | 313,500 | - | - | Stock Option (Right to Buy) | |
| EQRx Inc | Clive A. Meanwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 42,946 | 42,946 | - | - | Earn-out Shares |